Company / FCF Margin
AGIOS PHARMACEUTICALS, INC. FCF Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
-698.3%
FY2025
5-year range
-1107.5% / -698.3%
FY2021-FY2025
Trend
+34.9%
vs FY2024
Sector context
#117 of 133
Health Care
What the data says
AGIOS PHARMACEUTICALS, INC.'s fcf margin of -698.3% is lower than 88% of companies in the Health Care sector (FY2025). FCF Margin has fluctuated over the past 8 years, ranging from -2758.5% in FY2017 to 41.0% in FY2018.
Based on SEC 10-K filings.
-698.3% in FY2025 with a 5-year CAGR of -368.4%.
Improved from -1107.5% to -698.3% over the past 2 years.
Health Care sector context is included.
FCF Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -368.4pp
- 10-Year Change
- -
Sector benchmark
Bottom 12% in Health CareTop 88% of 133This company -698.3% Sector average -632.8%
▼
-10.3% below sector average
Key checks
Key Insights
- In FY2025, fcf margin increased 34.9% year-over-year.
- Currently 65.5pp below the Health Care sector average.
- Peak fcf margin was recorded in FY2018.
- Lowest fcf margin in the period was in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 3.83 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -698.3% | +34.9% |
| FY2024 | -1072.7% | +3.1% |
| FY2023 | -1107.5% | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | -329.9% | -1.7% |
| FY2019 | -324.5% | -891.7% |
| FY2018 | 41.0% | +101.5% |
| FY2017 | -2758.5% | -6829.6% |
| FY2016 | 41.0% | +124.3% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026